Nucleix
Urine-based test for detecting bladder cancer
Total raised
€49M
€49,021,000
Funding rounds
2
Investors
3
distinct backers
Active since
2016-04
latest 2021-04
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood12
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood16
base rate 12% (2+ rounds)
- ▲ €30M+ raised
- ▲ 18y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-04-07 | Other | €46M | RA Capital Management | View deal → |
| 2016-05-01 | Seed | €2.7M | Aurum Ventures,OrbiMed | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Roivant Sciences€1.2BSwitzerland · Healthtech
- CMR Surgical€1.2BUK · Healthtech
- Trax€791MIsrael · Software
- Oura Health€779MFinland · Healthtech